Champions Oncology

CSBRNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$73.629 M

$5.29 +0.57%

Close of 22 Sept 2026

Revenue

$59.4M

#2674 by revenue

Earnings

-$1.18K

Loss-making

Shares outstanding

13,893,569

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#117Greenland MinesGRML$82.8M
#118Kalaris TherapeuticsKLRS$77.1M
#119Champions OncologyCSBR$73.6M
#120BioStem TechnologiesBSEM$71.0M
#121OKYO PharmaOKYO$70.8M

What if Champions Oncology were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,172,204

Per share 410,625× higher

Bitcoin $1.74T

$125,131.76

Per share 23,654× higher

Nvidia $5.52T

$396,288.37

Per share 74,913× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Champions Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.